These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
803 related articles for article (PubMed ID: 22198387)
1. Seizure suppression and neuroprotection by targeting the purinergic P2X7 receptor during status epilepticus in mice. Engel T; Gomez-Villafuertes R; Tanaka K; Mesuret G; Sanz-Rodriguez A; Garcia-Huerta P; Miras-Portugal MT; Henshall DC; Diaz-Hernandez M FASEB J; 2012 Apr; 26(4):1616-28. PubMed ID: 22198387 [TBL] [Abstract][Full Text] [Related]
2. Increased neocortical expression of the P2X7 receptor after status epilepticus and anticonvulsant effect of P2X7 receptor antagonist A-438079. Jimenez-Pacheco A; Mesuret G; Sanz-Rodriguez A; Tanaka K; Mooney C; Conroy R; Miras-Portugal MT; Diaz-Hernandez M; Henshall DC; Engel T Epilepsia; 2013 Sep; 54(9):1551-61. PubMed ID: 23808395 [TBL] [Abstract][Full Text] [Related]
3. Transient P2X7 Receptor Antagonism Produces Lasting Reductions in Spontaneous Seizures and Gliosis in Experimental Temporal Lobe Epilepsy. Jimenez-Pacheco A; Diaz-Hernandez M; Arribas-Blázquez M; Sanz-Rodriguez A; Olivos-Oré LA; Artalejo AR; Alves M; Letavic M; Miras-Portugal MT; Conroy RM; Delanty N; Farrell MA; O'Brien DF; Bhattacharya A; Engel T; Henshall DC J Neurosci; 2016 Jun; 36(22):5920-32. PubMed ID: 27251615 [TBL] [Abstract][Full Text] [Related]
4. Hippocampal damage after intra-amygdala kainic acid-induced status epilepticus and seizure preconditioning-mediated neuroprotection in SJL mice. Tanaka K; Jimenez-Mateos EM; Matsushima S; Taki W; Henshall DC Epilepsy Res; 2010 Feb; 88(2-3):151-61. PubMed ID: 19931419 [TBL] [Abstract][Full Text] [Related]
5. P2X7 receptor inhibition interrupts the progression of seizures in immature rats and reduces hippocampal damage. Mesuret G; Engel T; Hessel EV; Sanz-Rodriguez A; Jimenez-Pacheco A; Miras-Portugal MT; Diaz-Hernandez M; Henshall DC CNS Neurosci Ther; 2014 Jun; 20(6):556-64. PubMed ID: 24750893 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of P2X7 Receptor Ameliorates Nuclear Factor-Kappa B Mediated Neuroinflammation Induced by Status Epilepticus in Rat Hippocampus. Huang C; Chi XS; Li R; Hu X; Xu HX; Li JM; Zhou D J Mol Neurosci; 2017 Oct; 63(2):173-184. PubMed ID: 28856625 [TBL] [Abstract][Full Text] [Related]
7. P2X7 receptor differentially modulates astroglial apoptosis and clasmatodendrosis in the rat brain following status epilepticus. Kim JE; Ryu HJ; Yeo SI; Kang TC Hippocampus; 2011 Dec; 21(12):1318-33. PubMed ID: 20848604 [TBL] [Abstract][Full Text] [Related]
8. Pilocarpine-Induced Status Epilepticus Increases the Sensitivity of P2X7 and P2Y1 Receptors to Nucleotides at Neural Progenitor Cells of the Juvenile Rodent Hippocampus. Rozmer K; Gao P; Araújo MGL; Khan MT; Liu J; Rong W; Tang Y; Franke H; Krügel U; Fernandes MJS; Illes P Cereb Cortex; 2017 Jul; 27(7):3568-3585. PubMed ID: 27341850 [TBL] [Abstract][Full Text] [Related]
9. Antagonism of P2X7 receptors enhances lorazepam action in delaying seizure onset in an in vitro model of status epilepticus. Garcia-Durillo M; Frenguelli BG Neuropharmacology; 2023 Nov; 239():109647. PubMed ID: 37459909 [TBL] [Abstract][Full Text] [Related]
10. Epileptic tolerance is associated with enduring neuroprotection and uncoupling of the relationship between CA3 damage, neuropeptide Y rearrangement and spontaneous seizures following intra-amygdala kainic acid-induced status epilepticus in mice. Jimenez-Mateos EM; Mouri G; Conroy RM; Henshall DC Neuroscience; 2010 Dec; 171(2):556-65. PubMed ID: 20837105 [TBL] [Abstract][Full Text] [Related]
11. Resistance of immature hippocampus to morphologic and physiologic alterations following status epilepticus or kindling. Haas KZ; Sperber EF; Opanashuk LA; Stanton PK; Moshé SL Hippocampus; 2001; 11(6):615-25. PubMed ID: 11811655 [TBL] [Abstract][Full Text] [Related]
12. Therapeutic window of opportunity for the neuroprotective effect of valproate versus the competitive AMPA receptor antagonist NS1209 following status epilepticus in rats. Langer M; Brandt C; Zellinger C; Löscher W Neuropharmacology; 2011; 61(5-6):1033-47. PubMed ID: 21736883 [TBL] [Abstract][Full Text] [Related]
13. Effects of P2X7 receptor antagonists on hypoxia-induced neonatal seizures in mice. Rodriguez-Alvarez N; Jimenez-Mateos EM; Engel T; Quinlan S; Reschke CR; Conroy RM; Bhattacharya A; Boylan GB; Henshall DC Neuropharmacology; 2017 Apr; 116():351-363. PubMed ID: 28082183 [TBL] [Abstract][Full Text] [Related]
14. P2X purinoceptors as a link between hyperexcitability and neuroinflammation in status epilepticus. Henshall DC; Engel T Epilepsy Behav; 2015 Aug; 49():8-12. PubMed ID: 25843343 [TBL] [Abstract][Full Text] [Related]
15. Inflammatory events in hippocampal slice cultures prime neuronal susceptibility to excitotoxic injury: a crucial role of P2X7 receptor-mediated IL-1beta release. Bernardino L; Balosso S; Ravizza T; Marchi N; Ku G; Randle JC; Malva JO; Vezzani A J Neurochem; 2008 Jul; 106(1):271-80. PubMed ID: 18384650 [TBL] [Abstract][Full Text] [Related]
16. Mechanism of microglia neuroprotection: Involvement of P2X7, TNFα, and valproic acid. Masuch A; Shieh CH; van Rooijen N; van Calker D; Biber K Glia; 2016 Jan; 64(1):76-89. PubMed ID: 26295445 [TBL] [Abstract][Full Text] [Related]
17. Differential GABA(A) subunit expression following status epilepticus in seizure-prone and seizure-resistant rats: a putative mechanism for refractory drug response. Gilby KL; Da Silva AG; McIntyre DC Epilepsia; 2005; 46 Suppl 5():3-9. PubMed ID: 15987246 [TBL] [Abstract][Full Text] [Related]
18. The roles of P2X7 receptor in regional-specific microglial responses in the rat brain following status epilepticus. Choi HK; Ryu HJ; Kim JE; Jo SM; Choi HC; Song HK; Kang TC Neurol Sci; 2012 Jun; 33(3):515-25. PubMed ID: 21845474 [TBL] [Abstract][Full Text] [Related]
19. Altered P2X7-receptor level and function in mouse models of Huntington's disease and therapeutic efficacy of antagonist administration. Díaz-Hernández M; Díez-Zaera M; Sánchez-Nogueiro J; Gómez-Villafuertes R; Canals JM; Alberch J; Miras-Portugal MT; Lucas JJ FASEB J; 2009 Jun; 23(6):1893-906. PubMed ID: 19171786 [TBL] [Abstract][Full Text] [Related]
20. Feasibility study of B16 melanoma therapy using oxidized ATP to target purinergic receptor P2X7. Hattori F; Ohshima Y; Seki S; Tsukimoto M; Sato M; Takenouchi T; Suzuki A; Takai E; Kitani H; Harada H; Kojima S Eur J Pharmacol; 2012 Nov; 695(1-3):20-6. PubMed ID: 22981895 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]